Company intelligence / Profile preview
Optimum Therapeutics
Carlsbad, California, USAoptimumtx.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Optimum Therapeutics has developed platform technologies integrating tumor-selective nanoparticles/microparticles for enhanced drug delivery into solid tumors. Their approach combines targeted delivery vehicles with noncytotoxic sensitizers and predictive computational models. Funded by multiple SBIR and RO1 grants from NCI; collaborative agreements exist with pharmaceutical companies and academic partners. Early-stage clinical results focus on improved penetration/delivery of chemotherapeutic agents in solid tumors.
- Therapeutic areas
- Oncology
- Modalities
- NanoparticleMicroparticleSmall molecule
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
03
Partnerships
Collaborative agreements with pharmaceutical companies
Beyond the preview
Go deeper on Optimum Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Optimum Therapeutics.